Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma‐induced malignant pleural effusion

E-ISSN： 1759-7714|9|2|298-304

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.9, Iss.2, 2018-02, pp. : 298-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinicopathological characteristics and outcomes of ROS1‐rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 413-420

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medical thoracoscopy in MALT lymphoma causing pleural effusion: A case report

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 372-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine‐induced killer cells

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 458-463

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differential diagnosis and cancer staging of a unique case with multiple nodules in the lung – lung adenocarcinoma, metastasis of colon adenocarcinoma, and colon adenocarcinoma metastasizing to lung adenocarcinoma

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 363-367

John Wiley & Sons Inc

Access to resources Recommend Favorite

Myelomatous pleural effusion involvement in 23 patients with multiple myeloma: A single‐center clinical analysis

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 359-362

John Wiley & Sons Inc

Access to resources Recommend Favorite